NTRA News and Press, Natera Inc. From 04/16/19

SAN CARLOS, Calif. , April 16, 2019 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA), Cancer Research UK , Imperial College London  and the University of Leicester , today announced the publication of results of a clinical study demonstrating that the Signatera&#x...

CareDx ( CDNA +4.4% ) has filed a second lawsuit against Natera ( NTRA +3.7% ) accusing it of misleading doctors and patients about its kidney transplant technology compared to CDNA's AlloSure via its "false advertising campaign" claiming that its technology is superior to AlloSure. ...

SAN CARLOS, Calif. , April 10, 2019 /PRNewswire/ --  Natera, Inc. (NASDAQ: NTRA) Natera, a leader in cell-free DNA testing, today announced plans to commercialize a research-use-only (RUO) service for whole exome sequencing (WES) of circulating tumor DNA, using plasma samples from p...

The Federal Reserve Board and the Federal Deposit Insurance Corp. say they didn't identify any deficiencies or weaknesses in the 2017 resolution plans, known as "living wills," for the 14 financial institutions evaluated. More news on: Natera, Inc., Ally Financial Inc., American Express ...

SAN CARLOS, Calif. , March 28, 2019 /PRNewswire/ --  Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that Palmetto MolDx has issued draft local coverage determination (LCD) for use of the company's new Prospera donor-derived cell-free D...

Natera ( NTRA +0.7% ) perks up on light volume on the heels of its announced collaboration with AML Therapeutics in a clinical trial evaluating the latter's therapeutic cancer vaccine candidate ATP128 in patients with stage IV colorectal cancer. More news on: Natera, Inc., Healthcare s...

SAN CARLOS, Calif. , March 26, 2019 /PRNewswire/ --  Natera, Inc.  (NASDAQ: NTRA), a global leader in cell-free DNA testing, will partner with AMAL Therapeutics on a clinical trial focused on stage IV colorectal cancer. This study adds to the growing number of pharmaceutical tri...

Deals and Financings InventisBio of Shanghai closed a $70 million Series C financing co-led by Advantech Capital and CMBI, followed by Pudong Innotek (see story ). Founded in 2013, InventisBio focuses on discovering and developing novel therapeutics for cancer and metabolic diseases. The co...

The following slide deck was published by Natera, Inc. in conjunction with their 2018 Q4 earnings Read more ...

Natera Inc. (NASDAQ:NTRA) shares are soaring up +20% this morning after the healthcare company released its Q4 and full 2018 earnings. The healthcare stock is seeing its biggest share rise today in well over six months. Investors seem pleased with Natera’s earnings, so if youȁ...